ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
New patent issued to 2032 for Neuren's trofinetide in Brazil
Published: 16/09/21, 02:43pm (AEST)•2 pages